Latest Headlines

  1. Genesis Reference Laboratories Launches Advanced PCR Measles Test To Enhance Early Detection And Outbreak Prevention 6/24/2025

    Genesis Reference Laboratories, a leader in diagnostic testing, is proud to announce the launch of its new Polymerase Chain Reaction (PCR) Measles Test, a highly sensitive and rapid method for detecting the measles virus.

  2. Galatea Bio And Fabric Genomics Partner To Deliver Comprehensive Genetic Testing For Common Diseases 6/23/2025

    Galatea Bio and Fabric Genomics, a GeneDx company, announced today a strategic collaboration to enhance genetic testing by incorporating both rare pathogenic variant analysis and polygenic risk scoring (PRS) to assess genetic susceptibility to common diseases.

  3. Quanterix Expands Reach With IVD And Large Reference Labs 6/23/2025

    Quanterix Corporation a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that the HD-X Simoa Immunoassay Analyzer has received Class 1 Medical Device registration by the Ministry of Food and Drug Safety (MFDS) in South Korea through its regional distribution partner, HS Biosystems.

  4. MedHub-AI Receives PMDA Approval In Japan For AutocathFFR® 6/19/2025

    MedHub-AI, a global leader in AI-powered cardiovascular diagnostics, announced today that the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has approved AutocathFFR®, the company's non-invasive, AI-driven software solution for evaluating coronary physiology.

  5. Labviva Showcases Advanced AI Procurement Tools At The R&D Procurement And Sourcing In Pharma Summit 2025 6/19/2025

    Labviva, the leading AI procurement platform for life sciences, today announced its plans to demonstrate how pharmaceutical and biotech companies can leverage AI for laboratory procurement to drive cost and resource efficiencies and accelerate the pace of scientific innovation.

  6. Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test 6/18/2025

    Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that Hoag, a nationally-recognized regional healthcare delivery network, has launched a comprehensive, integrated esophageal precancer testing program using Lucid Diagnostics' EsoGuard® Esophageal DNA Test.

  7. QIAGEN And GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership 6/18/2025

    QIAGEN and GENCURIX, Inc. today announced a new partnership to develop oncology assays for use on the QIAcuityDx platform, a high-performance digital PCR system designed for clinical diagnostics.

  8. Hoag Digestive Health Institute Introduces Revolutionary New Precancer Screening Tool In Fight Against Esophageal Cancer 6/18/2025

    Hoag has become the first hospital in the United States to offer a comprehensive, on-site program for a revolutionary, non-invasive esophageal cancer screening tool that requires no sedation and can be administered in a few minutes in a doctor's office visit.

  9. New Test Could Save Lives From Deadly Fungal Infection Which Spiked During Pandemic 6/18/2025

    A new lateral-flow test could one day save lives across the world through early detection of a deadly fungal disease which dramatically spiked during the COVID-19 pandemic.

  10. Automated Handling For Liquid And Solid Samples 6/18/2025

    Micronic is proud to introduce the second-generation of the Tube Handler HT500, featuring an enhanced design for even more efficient and reliable sample handling in the laboratory.